SCIENCE NEWS Blood-Producing Stem Cells Explained A team of researchers have made significant progress in the understanding of hematopoietic stem cells. [Press release from the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal discussing online prepublication in Cell Stem Cell] ‘Stem Cell Detectives’ Uncover Potential Cancer Cause Australian researchers have uncovered a new mutation in stem cells that may be linked to the development of leukemia, breast and colon cancer. [Press release from The Australian National University discussing online prepublication in Blood]
|
|
CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal) LABORATORY RESEARCH Musashi-2 Regulates Normal Hematopoiesis and Promotes Aggressive Myeloid Leukemia Researchers demonstrate that Msi2 is the predominant form expressed in hematopoietic stem cells (HSCs), and its knockdown leads to reduced engraftment and depletion of HSCs in vivo. [Nat Med] A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-Renewal Researchers report that human hematopoietic stem cells exhibit delayed DNA double-strand break rejoining, persistent gammaH2AX foci, and enhanced p53- and ASPP1-dependent apoptosis after gamma-radiation compared to progenitors. [Cell Stem Cell] Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis The results demonstrate that quiescence is a double-edged sword that renders hematopoietic stem cells intrinsically vulnerable to mutagenesis following DNA damage. [Cell Stem Cell] A Recessive Screen for Genes Regulating Hematopoietic Stem Cells Here, researchers demonstrate that chemical mutagenesis of mice combined with advances in hematopoietic stem cell reagents and genome resources can efficiently recover recessive mutations and identify genes essential for generation and proliferation of definitive hematopoietic stem cells and/or their progeny. [Blood] Trib1 Links the MEK1/ERK Pathway in Myeloid Leukemogenesis Researchers report that interaction between Trib1 and MEK1 is required for Trib1-induced leukemogenesis. [Blood] Kinetics and Specificity of FLVCR Export Function and its Dependence on Hemopexin Using 55Fe-heme and the fluorescent heme analog zinc mesoporphyrin, researchers investigated whether export by Feline Leukemia Virus Subgroup-C Receptor (FLVCR) depends on the availability and avidity of extracellular heme-binding proteins. [J Biol Chem] Essential Role of p400/mDomino Chromatin-Remodeling ATPase in Bone Marrow Hematopoiesis and Cell-Cycle Progression Here, researchers generated a conditional knockout mouse for the p400/mDomino gene, and investigated p400/mDomino’s role in adult bone marrow hematopoiesis and in the cell-cycle progression of embryonic fibroblasts. [J Biol Chem] CLINICAL RESEARCH Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00 Short imatinib pulses were added to chemotherapy to improve the long-term survival of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, to optimize complete remission and stem-cell transplantation rates. [J Clin Oncol] Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia (AML) Are Associated with Patient Response to Standard Induction Therapy Researchers applied single-cell network profiling (SCNP) using flow cytometry, a tool that allows a comprehensive functional assessment of intracellular signaling pathways in heterogeneous tissues, to two training cohorts of AML samples (n = 34 and 88) to predict the likelihood of response to induction chemotherapy. [Clin Cancer Res]
|
|
POLICY NEWS Harold Varmus Sworn in as National Cancer Institute’s 14th Director Nobel Prize winner Harold E. Varmus, M.D., today took the oath of office to become the National Cancer Institute’s (NCI) 14th director. NCI is one of the 27 Institutes and Centers that comprise the National Institutes of Health (NIH). [National Institutes of Health, United States] Britain Delays Controversial Assessment Scheme for Research Britain’s new science minister made good a manifesto pledge today when he announced that the coalition government would delay for one year the implementation of the controversial Research Excellence Framework, a system of assessing university departments for the distribution of funding. [Ministry of Universities and Science, United Kingdom] Spanish Science Spending Lockdown Spain’s science and innovation minister said that research funding will be “frozen or minimally reduced” as a result of government-wide austerity measures. [Ministry of Science and Innovation, Spain] Maryland Stem Cell Research Commission Elects Margaret Conn Himelfarb as Chair The Maryland Stem Cell Research Commission announced that it has elected Margaret Conn Himelfarb as chair and Bowen P. Weisheit, Jr. as vice chair. [Maryland Stem Cell Research Commission, United States] Clinical Laboratory Improvement Advisory Committee (CLIAC); Notice of Meeting [Centers for Disease Control and Prevention, United States] Request for Information (RFI) on the National Institutes of Health Plan to Develop the Genetic Testing Registry; Notice [National Institutes of Health, United States] Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting [National Institutes of Health, United States] National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting [National Institutes of Health, United States] July 26-27, 2010: Blood Products Advisory Committee Meeting Waivers for Conflicts of Interest [Food and Drug Administration, United States]
|
|
EVENTS Select Biosciences 3rd Annual Stem Cells Europe Conference August 24-25, 2010 Edinburgh, Scotland Select Biosciences 2nd Annual World Biobanking Summit August 24-25, 2010 Edinburgh, Scotland Select Biosciences Inaugural Cellular Therapy Summit August 24-25, 2010 Edinburgh, Scotland The European Molecular Biology Organization (EMBO) Meeting 2010 September 4-7, 2010 Barcelona, Spain International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting September 11-14, 2010 Belgirate, Italy Stem Cells USA & Regenerative Medicine Congress 2010 September 13-15, 2010 Philadelphia, United States Society for Hematology and Stem Cells (ISEH) 2010 Meeting September 15-18, 2010 Melbourne, Australia Sickle Cell Disease Association of America (SCDAA) 38th Annual Convention September 21-24, 2010 Washington D.C., United States American Society of Hematology (ASH) State-of-the-Art Symposium 2010 September 24-25, 2010 Chicago, United States Society for the Advancement of Blood Management® (SABM®) 2010 Annual Meeting September 24-26, 2010 San Juan, Puerto Rico Stem Cells and Regeneration October 3-9, 2010 Woods Hole, United States American Association of Blood Banks (AABB) Annual Meeting 2010 October 9-12, 2010 Baltimore, United States Fraunhofer Life Science Symposium Leipzig 2010 October 29-30, 2010 Leipzig, Germany 52nd American Society of Hematology (ASH) Annual Meeting and Exposition December 4-7, 2010 Orlando, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Senior Scientist – Magnetic Cell Separation (STEMCELL Technologies) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News. Visit here to post your career opportunities.
Have we missed an important article or publication in Hematopoiesis News? Click here to submit! Comments or Suggestions? Email info@connexoncreative.com with your feedback.
|
| |
|